AACG (AACG) Stock Price & Analysis
AACG (AACG) fell 0.46% to USD 1.08 as of June 10, 2026 at 10:59 UTC, according to Nexqual real-time market data.
AACG last closed at USD 1.08; the session ranged USD 1.04–1.17 on volume of 7,076 shares. Market capitalization is $46.45M, with a 52-week range of USD 0.74–2.58 (NCM). Source: Nexqual, June 10, 2026 at 10:59 UTC.
Key Statistics (as of June 10, 2026 at 10:59 UTC)
| Price | USD 1.08 |
|---|---|
| Change | ▼ 0.46% (down) |
| Previous Close | USD 1.08 |
| Open | USD 1.09 |
| Day Range | USD 1.04 – 1.17 |
| 52-Week Range | USD 0.74 – 2.58 |
| Volume | 7,076 shares |
| Market Cap | $46.45M |
| Exchange | NCM |
Technical Analysis (AACG)
Nexqual's technical model rates AACG "SELL" based on 1 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 10:59 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 43.14 (neutral) |
| vs SMA50 | Below (USD 1.1) |
| MACD | -0.01 (negative) |
Analyst Ratings (AACG)
Wall Street analysts rate AACG "None", per Nexqual as of June 10, 2026 at 10:59 UTC.
| Consensus Rating | None |
|---|
Earnings (AACG)
Source: Nexqual, June 10, 2026 at 10:59 UTC.
Financials & Fundamentals (AACG)
| Total Revenue | $527.01M |
|---|---|
| Revenue Growth (YoY) | -11.70% |
| Gross Margin | +46.87% |
| Operating Margin | +12.22% |
| Profit Margin | -4.57% |
| ROE | -6.18% |
| Debt / Equity | 143.68 |
| Current Ratio | 2.59 |
| Total Cash | $85.24M |
| Total Debt | $45.95M |
Source: Nexqual, June 10, 2026 at 10:59 UTC.
Financial Health Score (AACG)
Nexqual rates AACG's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 10:59 UTC.
| Growth | Critical — Revenue -100% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $85M cash vs $46M debt, net cash position |
| Cash Flow | Mixed — No data |
| Efficiency | Critical — ROE -6%, ROA 5.0% |
Ownership (AACG)
| Insider Ownership | +5.42% |
|---|---|
| Institutional Ownership | +11.68% |
| Shares Outstanding | 43.21M |
| Float | 5.98M |
| Short % of Float | +0.12% |
Source: Nexqual, June 10, 2026 at 10:59 UTC.
Leadership (AACG)
AACG is led by Xiaofeng Ma (age 61), Co-Founder, Chairman & CEO, per Nexqual as of June 10, 2026 at 10:59 UTC.
| Co-Founder, Chairman & CEO | Xiaofeng Ma (age 61) |
|---|---|
| President & Director | Jun Zhang (age 52) |
| Chief Financial Officer | Ruobai Sima (age 43) |
Major Backers & Investors (AACG)
Notable institutional backers of AACG include Renaissance Technologies, Citadel, according to Nexqual as of June 10, 2026 at 10:59 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Renaissance Technologies | 0.14% |
| Citadel | 0.14% |
Source: Nexqual, June 10, 2026 at 10:59 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CMPS | COMPASS Pathways Plc - American | USD 11.26 | ▼ 7.02% |
| HELP | Cybin Inc. | USD 3.92 | ▼ 5.54% |
| DFTX | Definium Therapeutics, Inc. | USD 22.95 | ▼ 2.55% |
| AAME | Atlantic American Corporation | USD 1.76 | ▲ 5.39% |
| NCTY | The9 Limited - American Deposit | USD 4.35 | ▼ 7.25% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 10:59 UTC. This page is informational and not investment advice.